Comparison of Cerenkov luminescence imaging (CLI) and gamma camera imaging for visualization of let-7 expression in

Weidong Yang1, Weiwei Qin, Zhenhua Hu

  • 1Department of Nuclear Medicine, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, 710032, China.

Abstract

Insights

This study demonstrates Cerenkov luminescence imaging (CLI) and gamma camera imaging can visualize let-7 microRNA (miRNA) expression in lung adenocarcinoma cells. This novel method uses miRNA-regulated reporter genes to detect miRNA levels noninvasively.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biomedical Imaging

Background:

  • MicroRNAs (miRNAs) play a crucial role in tumorigenesis and are potential targets for cancer diagnosis.
  • Visualizing miRNA expression is essential for understanding their role in diseases like lung adenocarcinoma.

Purpose of the Study:

  • To develop and evaluate a novel method for visualizing let-7 miRNA expression in lung adenocarcinoma A549 cells.
  • To utilize Cerenkov luminescence imaging (CLI) and gamma camera imaging for noninvasive miRNA detection.

Main Methods:

  • Constructed a fusion gene (hNIS-RU) where hNIS expression is regulated by let-7 binding to the ras gene 3'-UTR.
  • Transfected A549 cells with hNIS or hNIS-RU, and co-transfected with let-7 or mir-143 primers.
  • Incubated cells with (131)I and performed CLI, gamma camera imaging, and gamma counting.

Main Results:

  • CLI and gamma camera imaging successfully visualized (131)I uptake, reflecting hNIS-RU expression levels.
  • (131)I uptake decreased in hNIS-RU transfected cells due to let-7 suppression, correlating with pri-let-7 concentration.
  • CLI demonstrated high correlation with gamma camera imaging (r(2)=0.9893) and radioactivity counting (0.9779).

Conclusions:

  • miRNA-regulated reporter genes can mediate radionuclide uptake for noninvasive miRNA detection.
  • CLI and gamma camera imaging offer a new approach for visualizing miRNA expression in cells.
  • This technique holds promise for advancing molecular diagnostics in cancer research.

Related Concept Videos